BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Leukocyte
,
Human chorionic gonadotropin
,
Cisplatin
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TSC2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pituitary gland
Testes
Fetal lung
Cerebellum
Neutrophil of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pulmonary lymphangioleiomyomatosis
Neurocutaneous syndrome
Interstitial lung disease
Irritable bowel syndrome
Muscle cachexia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ceftazidime
Talampicillin
repaglinide
Azaperone
Pituitary Adenylate Cyclase-Activating Polypeptide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir181b1
SHC2
PSMD2
CASP9
TSC2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Analysis of a patient with tuberous sclerosis complex due to mosaicism TSC2 mutation].
Identification of a novel heterozygous TSC2 splicing variant in a patient with Tuberous sclerosis co…
Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer.
TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solita…
A Rare Case of Progressive Malignant Triton Tumor With Rare Somatic Mutation in TSC2 Gene.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Everolimus for Cancer With TSC1 or TSC2 Mutation
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Altera…
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/o…
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutation…
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ